GVR Report cover U.S. Cath Labs Market Size, Share & Trends Report

U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services (Therapeutic Services, Diagnostic Services), Equipment), By Facility Type (Independent Labs, Hospital Based Labs), And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68039-160-4
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Report Overview

The U.S. cath labs market size was valued at USD 16.2 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% from 2020 to 2027. This is attributed to the growing demand for dedicated cardiac catheterization facilities and the rising prevalence of cardiovascular diseases in the country. In addition, the increasing burden of Heart Failure (HF) and Sudden Cardiac Arrest (SCA) cases among the middle-aged population due to unhealthy lifestyles and high adoption of technologically advanced products at the hospitals is also driving the market.

U.S. cath labs market size

Moreover, an increase in the number of coronary angioplasties due to a rise in cardiovascular cases, the growing geriatric population with a higher risk of cardiac disease, increased healthcare spending, and an increase in the number of interventional cardiologists in government and private hospitals are other factors expected to boost the market growth.

The rising healthcare costs and increasing pressure from the dynamic healthcare requirements are the factors boosting the demand for more number of cath labs in the country. Moreover, Medicare changed the reimbursement scenario for the cath lab systems based on their outcomes and not the quantity.

According to Medicare, it is estimated that the current reimbursement practice is costing more and it can be controlled with the use of technology-focused healthcare delivery. With this change in reimbursement policies, hospital-based cath labs have streamlined their workflow processes by adopting technologically-oriented cardiac catheterization systems for their cath labs.

Facility Type Insights

The hospital-based labs dominated the U.S. cath labs market and accounted for the largest revenue share of 95.5% in 2019. This is attributed to the high reimbursement rates associated with the cardiac procedures, increasing number of corporate hospitals with dedicated cath labs, and the growth of the hybrid cath labs model at the hospitals for treating various indications.

The elective Percutaneous Coronary Intervention (PCI) is the most common procedure performed in hospitals. Around 600,000 PCI procedures are performed annually in the U.S. These procedures have the highest aggregate costs of all cardiovascular procedures.

In the U.S., the market for cath labs is expected to witness high growth during the forecast period, due to an increase in the number of facilities each year in order to provide therapeutic and diagnostic services, for early detection and reduction in the mortality rate due to cardiac diseases. Unhealthy lifestyles and rising prevalence of associated risk factors such as smoking and alcohol consumption are the major factors adding to the high mortality rate due to heart diseases. Moreover, technological advancements, favorable government initiatives, and affordability of the interventions are the factors expected to propel the growth of the market for cath labs in the U.S. in the coming years. For instance, technology such as Nanostim-leadless dual-chamber pacemakers being developed by Abbott is expected to offer a great opportunity in terms of revenue.

Component Insights 

The services segment dominated the market for cath labs in the U.S. and accounted for the largest revenue share of more than 70.0% in 2019. This is attributed to the growing incidence of cardiovascular diseases in the U.S. With the technological advancements and integration and technology collaboration between the cath labs and the equipment providers, the equipment segment is expected to witness significant growth during the forecast period. The services segment is further divided into therapeutic and diagnostic services. The most common services offered at the cath labs include balloon angioplasty, coronary and left ventricular digital angiography, right and left heart catheterization, rotational atherectomy, coronary intravascular ultrasound, stent implantation, bifurcation and left main stenting, and thrombectomy. These services are offered for the treatment of various indications including acute coronary syndrome, acute myocardial infarction, and adult congenital heart disease.

U.S. cath labs market share

The stent placement dominated the therapeutic services segment in 2019, which can be attributed to the growing annual incidence of Percutaneous Coronary Interventions (PCI) in the region. The cardiac catheterization dominated the diagnostic segment, owing to the rising incidences of arterial blockage. According to the American Heart Association (AHA), coronary artery disease affects 16.5 million Americans.

Key Companies & Market Share Insights

Mergers and acquisitions, partnerships, and technology collaboration are the key strategies followed by the major players in the market. For instance, in October 2019, Siemens Healthineers acquired Corindus Vascular Robotics, Inc., a leading manufacturer of robotic systems for minimally invasive endovascular procedures. In another instance, in February 2019, Orchestra BioMed partnered With Terumo Corp. for the development and commercialization of Virtue Sirolimus-Eluting Balloon (SEB). Some of the prominent players in the U.S. cath labs market include:

  • Koninklijke Philips N.V.

  • Shimadzu Corporation

  • GE Healthcare

  • Johnson & Johnson

  • B. Braun Melsungen AG

  • Siemens Healthineers

  • Medtronic

U.S. Cath Labs Market Report Scope

Report Attribute


Market size value in 2020

USD 16.9 billion

Revenue forecast in 2027

USD 24.3 billion

Growth Rate

CAGR of 5.3% from 2020 to 2027

Base year for estimation


Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Component, facility type

Country scope

The U.S.

Key companies profiled

Koninklijke Philips N.V.; Shimadzu Corporation; GE Healthcare; Johnson & Johnson; B. Braun Melsungen AG; Siemens Healthineers; Medtronic

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the U.S. cath labs market report on the basis of component and facility type:

  • Component Outlook (Revenue, USD Million, 2016 - 2027)

    • Services

      • Therapeutic

        • Angioplasty

        • Stent Placement

        • Rotational Atherectomy

        • Thrombectomy

        • Cardioversion

        • Transcatheter aortic valve replacement (TAVR)

        • Others

      • Diagnostic

        • Angiography

        • Coronary Intravascular Ultrasound

        • Cardiac Catheterization

        • ECG/EKG

        • Fractional Flow Reserve (FFR)

        • Others

    • Equipment

  • Facility Type Outlook (Revenue, USD Million, 2016 - 2027)

    • Independent Labs

    • Hospital-Based Labs

Frequently Asked Questions About This Report




This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.